跳至主要内容
临床试验/NCT03317912
NCT03317912Unknown4 期

Effect of Peroperative Intravenous Infusion of Lignocaine on the Quality of Postoperative Sleep

University of Liege0 个研究点目标入组 40 人开始时间: 2017年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
40
主要终点
Time ratio between rapid eye movement sleep(REM) + Stage 3 sleep / Stage 1 + Stage 2 sleep

研究概览

简要总结

The aim of this clinical trial is to study the effect of an intravenous infusion of lidocaïne in a multimodal analgesic protocol on the architecture sleep during the first postoperative night.

详细描述

To study the effect of lidocaïne, we plan to include 40 patients, randomized in 2 groups, undergoing open prostate surgery in this randomized placebo-controlled trial.

Before anesthesia induction, these patients receive an intravenous lidocaine infusion (bolus 1,5 mg.kg-1 followed by a continuous infusion of 2mg.kg-1.h during 24 hours) or an equal volume of placebo. Then the anesthesia is induced with propofol, sufentanil et rocuronium. The postoperative analgesia is provided by paracetamol, tramadol and patient-controlled analgesia (PCA) with morphine or oral oxycodone. A polysomnography is registred on the preoperative night and on the first postoperative night.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Radical prostatectomy

排除标准

  • BMI > 30
  • Neurologic/psychiatric diseases or therapeutics, seizyres
  • Cardiac disease, second or third degree atrioventricular block
  • Obstructive sleep apnea syndrome
  • History of liver or renal insufficiency
  • and any contraindication to the anesthetic protocol of the study.

研究组 & 干预措施

Lidocaïne 2%

Active Comparator

Bolus 0.075ml/kg/h, following by continuous infusion 0.1ml/kg/h during surgery and 0.066ml/kg/h during 24h

干预措施: Lidocaïne 2% (Drug)

Placebo (for Lidocaïne)

Placebo Comparator

Bolus 0.075ml/kg/h, following by continuous infusion 0.1ml/kg/h during surgery and 0.066ml/kg/h during 24h

干预措施: Placebo (for Lidocaïne) (Drug)

结局指标

主要结局

Time ratio between rapid eye movement sleep(REM) + Stage 3 sleep / Stage 1 + Stage 2 sleep

时间窗: Postoperaty day 1

次要结局

  • Cumulative Opioid use(Postoperaty day 1)
  • Sleep latence(Postoperaty day 1)
  • Sleep time(Postoperaty day 1)
  • Quality of analgesia (Visual Analogic Scale)(Postoperaty day 1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean François Brichant

Professor

University of Liege

相似试验